biOasis Technologies Ord Shs V.BTI

Primary Symbol: V.BTI.H Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by geovaunon Mar 01, 2000 3:37pm

345 Views

Post# 1478662

RE: ANY INFORMATION SHOULD BE CONFIRMED

YOU GOT THAT ONE RIGHT ,GOOD MOVE AND FOR THE REST OF YOU STILL THINKING ABOUT IT, TO BUY ,WELL ,THINK SOME MORE , DO YOUR DD AND WHEN YOU FINISH THINK ABOUT THE MONEY YOU YOU COULD OF MADE,AGAIN..MAKE THE MOVE NOW!!!THE TRAIN IS PASSING,AND TOMORROW LONG GONE!!GET IN NOW WHILE YOU CAN

Bullboard Posts

Level up your trading with BMO InvestorLine’s enhanced features